Salarius Pharmaceuticals, Inc.·4

Feb 20, 4:07 PM ET

Rosenblum Mark J 4

4 · Salarius Pharmaceuticals, Inc. · Filed Feb 20, 2020

Insider Transaction Report

Form 4
Period: 2020-02-19
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Purchase

    Common Stock

    2020-02-19$0.95/sh+2,000$1,9007,000 total

Documents

1 file
  • 4
    wf-form4_158223286008604.xmlPrimary

    FORM 4